Nephros, Inc. (NEPH) financial statements (2022 and earlier)

Company profile

Business Address 380 LACKAWANNA PLACE
SOUTH ORANGE, NJ 07079
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,9737,3508,2788,1638,2495,1557,046
Cash and cash equivalents6,9737,3508,2788,1638,2495,1557,046
Receivables1,6411,5551,3821,7181,364901870
Inventory, net of allowances, customer advances and progress billings4,7954,6495,0874,6795,3045,3854,769
Inventory4,7954,6495,0874,6795,3045,3854,769
Prepaid expense    141  
Other undisclosed current assets225679310796314385
Total current assets:13,63413,62114,84014,66715,15411,75513,070
Noncurrent Assets
Finance lease, right-of-use asset 273033   
Operating lease, right-of-use asset 7878679451,0371,1171,171
Property, plant and equipment366382303311295302296
Intangible assets, net (including goodwill)2,8312,9011,8471,8911,9351,9792,023
Goodwill759759759759759759759
Intangible assets, net (excluding goodwill)2,0722,1421,0881,1321,1761,2201,264
Other noncurrent assets8910210489898989
Other undisclosed noncurrent assets730      
Total noncurrent assets:4,0164,1993,1513,2693,3563,4873,579
TOTAL ASSETS:17,65017,82017,99117,93618,51015,24216,649
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,7781,2141,5768297641,4831,765
Accounts payable1,3346411,1004954238871,316
Accrued liabilities444573476334341596449
Debt248255250244240575503
Business combination, contingent consideration, liability     6187
Other undisclosed current liabilities364354344335321315310
Total current liabilities:2,3901,8232,1701,4081,3252,3792,765
Noncurrent Liabilities
Long-term debt and lease obligation951642322991,6051,4151,600
Long-term debt, excluding current maturities95164232299846569692
Operating lease, liability    759846908
Other undisclosed noncurrent liabilities416503598692(752)(838)(900)
Total noncurrent liabilities:5116678309918531,4231,608
Total liabilities:2,9012,4903,0002,3992,9373,8024,373
Stockholders' equity
Stockholders' equity attributable to parent11,69512,27611,93712,48412,5228,3889,230
Common stock101010101099
Additional paid in capital147,346146,883145,378144,801144,296139,410139,243
Accumulated other comprehensive income64667068746965
Accumulated deficit(135,725)(134,683)(133,521)(132,395)(131,858)(131,100)(130,087)
Stockholders' equity attributable to noncontrolling interest3,0543,0543,0543,0533,0513,0523,046
Total stockholders' equity:14,74915,33014,99115,53715,57311,44012,276
TOTAL LIABILITIES AND EQUITY:17,65017,82017,99117,93618,51015,24216,649

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues2,7652,6372,2662,7362,3342,1211,577
Cost of revenue
(Cost of Goods and Services Sold)
(1,296)(1,225)(991)(1,149)(1,032)(896)(682)
Gross profit:1,4691,4121,2751,5871,3021,225895
Operating expenses(2,507)(2,574)(2,392)(2,605)(2,021)(2,157)(2,493)
Operating loss:(1,038)(1,162)(1,117)(1,018)(719)(932)(1,598)
Nonoperating income (expense)(4)8(9)481(28)(61)(33)
Other nonoperating income (expense)18(1)9(28)(61)(33)
Interest and debt expense (10)(11)482(15)(22)(30)
Loss from continuing operations before equity method investments, income taxes:(1,042)(1,164)(1,137)(55)(762)(1,015)(1,661)
Other undisclosed income from continuing operations before income taxes    11  
Net loss:(1,042)(1,164)(1,137)(55)(751)(1,015)(1,661)
Other undisclosed net income (loss) attributable to parent 211(482)(8)34
Net loss attributable to parent:(1,042)(1,162)(1,126)(537)(759)(1,012)(1,657)
Undistributed earnings (loss) allocated to participating securities, basic(61)(60)(60)(59)(61)(60)(60)
Net loss available to common stockholders, diluted:(1,103)(1,222)(1,186)(596)(820)(1,072)(1,717)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(1,042)(1,164)(1,137)(55)(751)(1,015)(1,661)
Other undisclosed comprehensive income (loss)(2)(2)13(488)176(53)(55)
Comprehensive loss:(1,044)(1,166)(1,124)(543)(575)(1,068)(1,716)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(61)(60)(60)(59)(419)6060
Comprehensive loss, net of tax, attributable to parent:(1,105)(1,226)(1,184)(602)(994)(1,008)(1,656)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: